Clinical trial
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
NCT00354094 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00354094 |
|---|---|
| Title | [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain. |
| Official title | A Phase 2B Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Postherpetic Neuralgia (PHN). |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | [S, S]-Reboxetine |
| Enrollment | 600 |
| Start date | Nov 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | Nov 8, 2007 |
| Countries | Argentina, Canada, Chile, Croatia, India, Lithuania, Mexico, Poland, Spain, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: